Grants and Contracts Details
Lyme disease, which is caused by the spirochete Borrelia burgdorferi, is generally treatable by a 2-4 week course of antibiotics. However, there is strong evidence from studies of human patients and experimental animals that antibiotics do not always clear B. burgdorferi infections. Studies of other bacterial species have revealed genetically-encoded physiological adaptations to antibiotic stresses, such as altering expression levels of target proteins or metabolic enzymes. To gain insight on whether the Lyme spirochete also adapts to antibiotic stresses, we will examine the transcriptomes and proteomes of B. burgdorferi that are exposed to sub-lethal and lethal concentrations of antibiotics that are commonly used to treat human Lyme disease infections. Results of these studies will indicate whether borrelial adaptive mechanisms should be targeted for development of improved therapeutics.
|Effective start/end date||6/6/17 → 5/31/20|
- National Institute of Allergy and Infectious Diseases: $166,145.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.